Back to Feed
总结
印度联邦卫生部长J.P.纳达（JP Nadda）近日在新德里发布《印度药典》2026（第10版）。报道指出，新版药典新增约121项药品专论并更新质量标准，用于指导药品检验、生产与监管，提升药品安全性与一致性。纳达同时强调印度药品标准获得更多国际认可，相关排名从第123位上升至第8位，预计将增强印度制药业合规与出口竞争力，并对公共卫生与患者用药安全产生长期影响。
正文
10th Edition of Indian Pharmacopoeia released by JP Nadda drugscontrol.org Union Health Minister Shri J. P. Nadda Releases 10th Edition of Indian Pharmacopoeia PIB India's Drug Standards Gain Global Recognition, Rise From 123rd To 8th Spot: Union Health Minister NDTV JP Nadda launches Indian Pharmacopoeia 2026, adds 121 new drugs monographs ANI News Nadda releases 10th edition of Indian Pharmacopoeia| India News Hindustan Times
发布时间：